1,000
Participants
Start Date
April 19, 2024
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2031
Cell-free DNA analysis
Analysis of cell-free DNA in blood plasma will involve targeted sequencing of key cancer-related genes, cell-free methylated DNA immunoprecipitation and high-throughput sequencing (cfMeDIP-seq), and shallow whole genome sequencing (sWGS).
NOT_YET_RECRUITING
BC Cancer Agency, Vancouver
NOT_YET_RECRUITING
Eastern Health, St. John's
NOT_YET_RECRUITING
IWK Health Centre, Halifax
NOT_YET_RECRUITING
The Hospital for Sick Children, Toronto
RECRUITING
Sinai Health System, Toronto
RECRUITING
University Health Network, Toronto
NOT_YET_RECRUITING
Women's College Hospital, Toronto
NOT_YET_RECRUITING
Jewish General Hospital, Montreal
Collaborators (2)
British Columbia Cancer Agency
OTHER
Eastern Health
OTHER
IWK Health Centre
OTHER
Jewish General Hospital
OTHER
Sinai Health System
OTHER
The Hospital for Sick Children
OTHER
University Health Network, Toronto
OTHER